Eudralex Volume 3 CHMP POSITION STATEMENT ON CREUTZFELDT-JACOB DISEASE and PLASMA-DERIVED AND URINE-DERIVED MEDICINAL PRODUCTS

Titel:
Eudralex Volume 3 CHMP POSITION STATEMENT ON CREUTZFELDT-JACOB DISEASE and PLASMA-DERIVED AND URINE-DERIVED MEDICINAL PRODUCTS
Internet:

https://www.gmp-navigator.com/files/guidemgr/chmp-position-statement-creutzfeldt-jacob-disease-and-plasma-derived-and-urine-derived-medicinal-products-revision-1_en.pdf

Herkunft/Verlag:

European Commission Enterprise and Industry DG, BREY 13/ 092, B - 1049 Brussels (Belgium), http://ec.europa.eu/enterprise/

Dokumentenart:
Positionspapier
Inhalt:
Revision der CPMP Stellungnahme(EMEA/CPMP/BEP/2879/02) zu CJD bei Plasma und urin basierten Arzneimitteln

Zurück